{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:14:08Z","timestamp":1788250448311,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00415-019-09586-5","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T04:28:17Z","timestamp":1571804897000},"page":"359-368","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["MOG-IgG-associated demyelination: focus on atypical features, brain histopathology and concomitant autoimmunity"],"prefix":"10.1007","volume":"267","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0522-1086","authenticated-orcid":false,"given":"Athanasios","family":"Papathanasiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu","family":"Tanasescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Francisca","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeet","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"O\u2019Donoghue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cris S.","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"key":"9586_CR1","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1007\/s00415-018-9122-2","volume":"266","author":"R Wynford-Thomas","year":"2019","unstructured":"Wynford-Thomas R, Jacob A, Tomassini V (2019) Neurological update: MOG antibody disease. J Neurol 266:1280\u20131286","journal-title":"J Neurol"},{"key":"9586_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/WCO.0000000000000446","volume":"30","author":"M Reindl","year":"2017","unstructured":"Reindl M, Jarius S, Rostasy K et al (2017) Myelin oligodendrocyte glycoprotein antibodies: how clinically useful are they? Curr Opin Neurol 30:295\u2013301","journal-title":"Curr Opin Neurol"},{"key":"9586_CR3","doi-asserted-by":"publisher","DOI":"10.1177\/1352458518811597","author":"LM Oliveira","year":"2018","unstructured":"Oliveira LM, Apostolos-Pereira SL, Pitombeira MS et al (2018) Persistent MOG-IgG positivity is a predictor of recurrence in MOG-IgG-associated optic neuritis, encephalitis and myelitis. Mult Scler. https:\/\/doi.org\/10.1177\/1352458518811597","journal-title":"Mult Scler"},{"issue":"3","key":"9586_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/practneurol-2017-001787","volume":"19","author":"M Jurynczyk","year":"2018","unstructured":"Jurynczyk M, Jacob A, Fujihara K et al (2018) Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations. Pract Neurol 19(3):187\u2013195","journal-title":"Pract Neurol"},{"key":"9586_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","volume":"15","author":"S Jarius","year":"2018","unstructured":"Jarius S, Paul F, Aktas O et al (2018) MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation 15:134","journal-title":"J Neuroinflammation"},{"key":"9586_CR6","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1212\/NXI.0000000000000089","volume":"2","author":"P Waters","year":"2015","unstructured":"Waters P, Woodhall M, O\u2019Connor KC et al (2015) MOG cell-based assay detects non-MS patient with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm 2:e89","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"9586_CR7","doi-asserted-by":"crossref","first-page":"e1250","DOI":"10.1212\/WNL.0000000000007096","volume":"92","author":"P Waters","year":"2019","unstructured":"Waters P, Komorowski L, Woodhall M et al (2019) A multicentre comparison of MOG-IgG cell-based assays. Neurology 92:e1250\u2013e1255","journal-title":"Neurology"},{"key":"9586_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuck","year":"2018","unstructured":"Wingerchuck DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:177\u2013189","journal-title":"Neurology"},{"key":"9586_CR9","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","volume":"140","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk M, Messina S, Woodhall MR et al (2017) Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain 140:3128\u20133138","journal-title":"Brain"},{"key":"9586_CR10","doi-asserted-by":"publisher","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","volume":"90","author":"A Cobo-Calvo","year":"2018","unstructured":"Cobo-Calvo A, Ruiz A, Maillart E et al (2018) Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study. Neurology 90:e1858\u2013e1869","journal-title":"Neurology"},{"key":"9586_CR11","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1212\/NXI.0000000000000322","volume":"4","author":"R Ogawa","year":"2017","unstructured":"Ogawa R, Nakashima I, Takahashi T et al (2017) MOG-antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy. Neurol Neuroimmunol Neuroinflamm 4:e322","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"9586_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jamaneurol.2017.3196","volume":"75","author":"SHM Hamid","year":"2018","unstructured":"Hamid SHM, Whittam D, Saviour M et al (2018) Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs aquaporin 4 IgG disease. JAMA Neurol 75:65\u201371","journal-title":"JAMA Neurol"},{"key":"9586_CR13","doi-asserted-by":"crossref","unstructured":"Jarius S, Ruprecht K, Kleiter I et al (2016) MOG-IgG in NMO and related disorders: a multicentre study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation 13:280","DOI":"10.1186\/s12974-016-0718-0"},{"key":"9586_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.msard.2019.01.021","volume":"29","author":"S Salma","year":"2019","unstructured":"Salma S, Khan M, Levy M et al (2019) Radiological characteristics of myelin oligodendrocyte glycoprotein antibody disease. Mult Scler Relat Disord 29:15\u201322","journal-title":"Mult Scler Relat Disord"},{"key":"9586_CR15","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/ene.13790","volume":"26","author":"L Wang","year":"2019","unstructured":"Wang L, ZhangBao J, Zhou L et al (2019) Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single-center cohort study in Shanghai, China. Eur J Neurol 26:168\u2013174","journal-title":"Eur J Neurol"},{"key":"9586_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3389\/fneur.2019.00415","volume":"10","author":"X Zhong","year":"2019","unstructured":"Zhong X, Zhou Y, Chang Y et al (2019) Seizure and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis in a retrospective cohort of chinese patients. Front Neurol 10:415","journal-title":"Front Neurol"},{"key":"9586_CR17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3389\/fneur.2018.00217","volume":"9","author":"GR Dos Passos","year":"2018","unstructured":"Dos Passos GR, Oliveira LM, da Costa BK et al (2018) MOG-IgG-associated optic neuritis, encephalitis, and myelitis: lessons learned from neuromyelitis optica spectrum disorder. Front Neurol 9:217","journal-title":"Front Neurol"},{"key":"9586_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1136\/jnnp-2018-319235","volume":"90","author":"T Komatsu","year":"2019","unstructured":"Komatsu T, Matsushima S, Kaneko K et al (2019) Perivascular enhancement in anti-MOG antibody demyelinating disease of the CNS. J Neurol Neurosurg Psychiatry 90:111\u2013112","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9586_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1756286418762083","volume":"11","author":"MS Weber","year":"2018","unstructured":"Weber MS, Derfuss T, Metz I et al (2018) Defining distinct features of anti-MOG antibody associated central nervous system demyelination. Ther Adv Neurol Disord 11:1\u201315","journal-title":"Ther Adv Neurol Disord"},{"key":"9586_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/acn3.164","volume":"2","author":"M Spadaro","year":"2015","unstructured":"Spadaro M, Gerdes LA, Mayer MC et al (2015) Histopathology and clinical course of MOG-antibody-associated encephalomyelitis. Ann Clin Transl Neurol 2:295\u2013301","journal-title":"Ann Clin Transl Neurol"},{"key":"9586_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.autrev.2017.11.011","volume":"17","author":"S Subesinghe","year":"2018","unstructured":"Subesinghe S, van Leuven S, Yalakki L et al (2018) Cocaine and ANCA associated vasculitis-like syndromes\u2014a case series. Autoimmun Rev 17:73\u201377","journal-title":"Autoimmun Rev"},{"key":"9586_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11926-017-0653-9","volume":"19","author":"J Marquez","year":"2017","unstructured":"Marquez J, Aguirre L, Munoz C et al (2017) Cocaine-levamisole-induced vasculitis\/vasculopathy syndrome. Curr Rheumatol Rep 19:36","journal-title":"Curr Rheumatol Rep"},{"key":"9586_CR23","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.3389\/fneur.2018.01166","volume":"9","author":"Y Zheng","year":"2019","unstructured":"Zheng Y, Zhang Y, Cai M et al (2019) Central Nervous System Involvement in ANCA-Associated Vasculitis: What Neurologists Need to Know. Front Neurol 9:1166","journal-title":"Front Neurol"},{"key":"9586_CR24","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519837705","author":"S Salama","year":"2019","unstructured":"Salama S, Khan M, Pardo S et al (2019) MOG antibody-associated encephalomyelitis\/encephalitis. Mult Scler. https:\/\/doi.org\/10.1177\/1352458519837705","journal-title":"Mult Scler"},{"key":"9586_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09440-8","author":"A Budhram","year":"2019","unstructured":"Budhram A, Mirian A, Le C et al (2019) Unilateral cortical FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis with Seizures (FLAMES): characterization of a distinct clinic-radiographic syndrome. J Neurol. https:\/\/doi.org\/10.1007\/s00415-019-09440-8","journal-title":"J Neurol"},{"key":"9586_CR26","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","volume":"75","author":"AS Lopez-Chiriboga","year":"2018","unstructured":"Lopez-Chiriboga AS, Majed M, Fryer J et al (2018) Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders. JAMA Neurol 75:1355\u20131363","journal-title":"JAMA Neurol"},{"key":"9586_CR27","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1212\/NXI.0000000000000257","volume":"3","author":"M Spadaro","year":"2016","unstructured":"Spadaro M, Gerdes LA, Krumbholz M et al (2016) Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 3:e257","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"9586_CR28","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1177\/1352458515591071","volume":"22","author":"A Cobo-Calvo","year":"2016","unstructured":"Cobo-Calvo A, Sepulveda M, Bernard-Valnet R et al (2016) Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implications. Mult Scler 22:312\u2013319","journal-title":"Mult Scler"},{"key":"9586_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.msard.2019.01.053","volume":"30","author":"T Baba","year":"2019","unstructured":"Baba T, Shinoda K, Watanabe M et al (2019) MOG antibody disease manifesting as progressive cognitive deterioration and behavioural changes with primary central nervous system vasculitis. Mult Scler Relat Disord 30:48\u201350","journal-title":"Mult Scler Relat Disord"},{"key":"9586_CR30","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1212\/NXI.0000000000000538","volume":"6","author":"K Patterson","year":"2019","unstructured":"Patterson K, Iglesias E, Nasrallah M et al (2019) Anti-MOG encephalitis mimicking small vessel CNS vasculitis. Neurol Neuroimmunol Neuroinflamm 6:e538","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"9586_CR31","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/ana.24117","volume":"75","author":"MJ Titulaer","year":"2014","unstructured":"Titulaer MJ, Hoftberger R, Iizuka T et al (2014) Overlapping demyelinating syndromes and anti-N-methyl-d-aspartate receptor encephalitis. Ann Neurol 75:411\u2013428","journal-title":"Ann Neurol"},{"key":"9586_CR32","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.msard.2018.01.007","volume":"20","author":"S Fan","year":"2018","unstructured":"Fan S, Xu Y, Ren H et al (2018) Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-d-aspartate) receptor encephalitis. Mult Scler Relat Dosord 20:144\u2013152","journal-title":"Mult Scler Relat Dosord"},{"key":"9586_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jaut.2019.04.007","volume":"101","author":"JF Baizabal-Carvallo","year":"2019","unstructured":"Baizabal-Carvallo JF (2019) The neurological syndromes associated with glutamic acid decarboxylase antibodies. J Autoimmun 101:35\u201347","journal-title":"J Autoimmun"},{"key":"9586_CR34","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519840746","author":"G Macaron","year":"2019","unstructured":"Macaron G, Ontaneda D (2019) MOG-related disorders: a new cause of imaging-negative myelitis? Mult Scler. https:\/\/doi.org\/10.1177\/1352458519840746","journal-title":"Mult Scler"},{"key":"9586_CR35","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519840747","author":"S Sundaram","year":"2019","unstructured":"Sundaram S, Nair SS, Jaganmohan D et al (2019) Relapsing lumbosacral myeloradiculitis: an unusual presentation of MOG antibody disease. Mult Scler. https:\/\/doi.org\/10.1177\/1352458519840747","journal-title":"Mult Scler"},{"key":"9586_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","volume":"15","author":"M Reindl","year":"2019","unstructured":"Reindl M, Waters P (2019) Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol 15:89\u2013102","journal-title":"Nat Rev Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09586-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09586-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09586-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T12:56:41Z","timestamp":1721912201000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09586-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["9586"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09586-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]},"assertion":[{"value":"31 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest.<b>Ethical standards<\/b>The study was approved by the Quality and Safety Committee of Nottingham University Hospitals NHS Trust.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}